Role of lysosome in healing neurological disorders by nano-bioengineering
- PMID: 38260032
- PMCID: PMC10800409
- DOI: 10.3389/fnins.2023.1331211
Role of lysosome in healing neurological disorders by nano-bioengineering
Abstract
Lysosomes primarily recognized as center for cellular 'garbage-disposing-unit', which has recently emerged as a crucial regulator of cellular metabolism. This organelle is a well-known vital player in the pathology including neurodegenerative disorders. In pathological context, removal of intracellular damaged misfolded proteins, organelles and aggregates are ensured by 'Autophagy' pathway, which initially recognizes, engulfs and seals the toxic cargo at the cytosolic environment. Thereafter the cell completes the task of encapsulated cargo elimination upon delivery of them to the terminal compartment - lysosome, which contains acid hydrolases, that are capable of degrading the abnormal protein-lipid-repertoire. The merge between inseparable 'Autophagy' and 'Lysosomal' pathways evolved into 'Autophagy-Lysosome Pathway (ALP)', through which cell ultimately degrades and recycles bio-materials for metabolic needs. Dysregulation of any of the steps of the multi-step ALP can contribute to the development and progression of disorders including Alzheimer's disease (AD), Parkinson's disease (PD), and Huntington's disease (HD). Therefore, targeting differential steps of ALP or directly lysosomes using nano-bioengineering approaches holds great promise for therapeutic interventions. This review aims to explore the role of distal autophagy pathway and proximal lysosomal function, as cellular degradative and metabolic hubs, in healing neurological disorders and highlights the contributions of nano-bioengineering in this field. Despite multiple challenges, this review underscores the immense potential of integrating autophagy-lysosomal biology with nano-bioengineering to revolutionize the field and provide novel therapeutic avenues for tackling neurological-neurodegenerative-disorders.
Keywords: amino acid; autophagy; bioengineering; lysosome; nanotechnology; neurodegenerative disorder.
Copyright © 2024 Raj and Bandyopadhyay.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Therapeutic Potential of Vital Transcription Factors in Alzheimer's and Parkinson's Disease With Particular Emphasis on Transcription Factor EB Mediated Autophagy.Front Neurosci. 2021 Dec 14;15:777347. doi: 10.3389/fnins.2021.777347. eCollection 2021. Front Neurosci. 2021. PMID: 34970114 Free PMC article. Review.
-
Autophagy and apoptosis dysfunction in neurodegenerative disorders.Prog Neurobiol. 2014 Jan;112:24-49. doi: 10.1016/j.pneurobio.2013.10.004. Epub 2013 Nov 6. Prog Neurobiol. 2014. PMID: 24211851 Review.
-
TRPMLs and TPCs: Targets for lysosomal storage and neurodegenerative disease therapy?Cell Calcium. 2022 May;103:102553. doi: 10.1016/j.ceca.2022.102553. Epub 2022 Feb 5. Cell Calcium. 2022. PMID: 35144097
-
Recent progress in the role of autophagy in neurological diseases.Cell Stress. 2019 Apr 29;3(5):141-161. doi: 10.15698/cst2019.05.186. Cell Stress. 2019. PMID: 31225510 Free PMC article. Review.
-
Protein Quality Control by Molecular Chaperones in Neurodegeneration.Front Neurosci. 2017 Apr 6;11:185. doi: 10.3389/fnins.2017.00185. eCollection 2017. Front Neurosci. 2017. PMID: 28428740 Free PMC article. Review.
Cited by
-
Inhibiting SNX14 Alleviates Epileptic Seizures by Regulating GluA2 Degradation via the Lysosomal Pathway.Mol Neurobiol. 2025 Aug;62(8):10902-10914. doi: 10.1007/s12035-025-04945-y. Epub 2025 Apr 16. Mol Neurobiol. 2025. PMID: 40237949
References
Publication types
LinkOut - more resources
Full Text Sources